Geisinger testing AI-powered vocal biomarker that identifies COPD flare-ups

Danville, Pa.-based Geisinger launched a study to test an algorithm for vocal biomarkers that can help detect exacerbations in chronic obstructive pulmonary disease patients.

Advertisement

The one-year research study examines artificial intelligence-powered voice analysis technology created by Healthymize, a health information technology startup. Study participants are required to perform daily voice recordings and fill out questionnaires to monitor their COPD.

“If we detect changes in a patient’s health condition earlier, we can reduce hospitalization and administer care in a timely manner at home,” said Paul F. Simonelli, MD, PhD, chair of pulmonary and critical care medicine at Geisinger, according to a news release. “We know that early detection of exacerbation improves outcomes, and Healthymize has the potential to present an easy-to-use solution that monitors patients from home.”

More articles on health IT:
4 common cyberattacks hospitals may encounter — Hackers stealing physician identities is one
IBM to lay off 2,000 employees this week
Epic and Humana partner: 5 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.